Federal · Nationwide

Federal cannabis attorney: DEA registration, compliance, and enforcement

Kocot Law represents state-licensed medical marijuana operators in the federal framework created by the April 2026 rescheduling of marijuana to Schedule III. Ryan Kocot prepares DEA registration applications under 21 C.F.R. § 1301.13(k), advises registrants on federal compliance, and represents them when DEA acts against a registration.
The rescheduling order

What changed in April 2026

On April 22, 2026, the Attorney General’s order changed marijuana’s federal classification for two categories of activity. It is a reclassification, not legalization: it creates a federal pathway for state-medical operators to obtain DEA registration and operate within federal law, together with the compliance obligations that come with a controlled-substance registration.
FDA-approved marijuana products: now Schedule III drugs, subject to standard pharmaceutical controls.
Marijuana covered by qualifying state medical licenses: eligible for DEA registration through the expedited pathway at 21 C.F.R. § 1301.13(k).
Adult-use marijuana: remains Schedule I. Adult-use-only activity has no federal registration pathway under the order.
The 60-day priority window: closed June 27, 2026. The registration pathway remains open; later applicants file without conditional operating authority during review.
Federal practice

Federal cannabis attorney practice areas

Federal cannabis law is new for most operators, and DEA’s procedural and substantive demands are unfamiliar. The work below covers the full arc: getting registered, staying compliant, and defending the registration.

DEA registration applications

Complete application packages for state-licensed medical operators across license types:
  • DEA Form 224 or Form 225, depending on operator type
  • 21 U.S.C. § 823(e)-(g) public-interest analysis
  • Background information for owners, officers, and other persons with substantial control
  • Premises documentation, including diversion-prevention measures
  • For manufacturers: cultivation area calculations, storage protocols, and Single Convention nominal-price documentation under § 1301.13(k)(6)

Federal compliance

Registration creates ongoing obligations:
  • 21 C.F.R. Part 1304 recordkeeping: initial and biennial inventory, receipts, distributions, and disposal records
  • Security under Part 1301 Subpart F: physical controls, alarm systems, and limited access
  • Quotas for manufacturers: procurement and manufacturing quotas under Part 1303
  • Reporting, including theft and significant-loss reports under § 1301.76(b), and suspicious-order monitoring for distributors and manufacturers
  • Federal-state integration, so DEA obligations line up with METRC, BioTrack, and other state track-and-trace and reporting regimes

Federal status change advisories

For existing state-licensed medical operators, a written analysis of where the rescheduling leaves the business:
  • Whether current activities qualify under § 1301.13(k)
  • Recommended filing timing now that the 60-day window has closed
  • The license, structure, and ownership disclosures the application will require
  • A state-federal compliance integration plan
  • The risk of continuing to operate without federal registration

Federal compliance audits and DEA enforcement

For registrants and pending applicants:
  • Audits of Part 1304 recordkeeping and Part 1301 security and operational controls, with severity-ranked findings, a remediation roadmap, and SOPs that satisfy both DEA and state regulators
  • DEA inspections and investigations
  • Orders to show cause and suspension or revocation proceedings under 21 U.S.C. § 824
  • Administrative hearings before DEA Administrative Law Judges
  • Coordination with state enforcement when state and federal proceedings overlap
Have a federal registration or DEA question? The first call is free.
Who this is for

Operator types we represent

Cultivators: registered as manufacturers under § 1301.13(k), including the cultivation area and Single Convention nominal-price requirements specific to marijuana cultivation.
Manufacturers and processors: producing concentrates, infused products, and finished medical marijuana products.
Distributors: moving product between licensed entities within the federal-state framework.
Dispensaries and retailers: dispensing to qualified medical patients under state programs.
Researchers: conducting marijuana research under state and federal authority.
Importers and exporters: managing international transactions under DEA and Single Convention frameworks.
Testing laboratories: registered as analytical labs under controlled-substance authority.
Multi-state operators: coordinating federal registration across several state license programs.
Multi-state operators

One federal record across several state licenses

Each state license is a separate basis for federal registration, but federal compliance has to work across the operator’s whole footprint. For multi-state operators, the work includes:
  • Sequencing federal applications across states in a defensible order
  • A unified compliance framework that satisfies DEA in every state of operation
  • Coordinating reporting across state regulators (California medical operators, New York registered organizations, Massachusetts medical treatment centers) and DEA
  • Ownership and control questions where federal registration meets state true-party-of-interest, ownership-disclosure, and equity-program rules

Federal FAQ

Is marijuana federally legal now?

No. Marijuana remains a federally controlled substance. The rescheduling moves FDA-approved marijuana products and qualifying state medical marijuana from Schedule I to Schedule III, which subjects those activities to federal controlled-substance regulation rather than federal prohibition. Adult-use marijuana remains Schedule I, and state-licensed activity outside the order’s scope remains federally prohibited.

Who is eligible for DEA registration under § 1301.13(k)?

State-licensed medical marijuana operators whose state license meets the qualifying criteria: licenses issued under bona fide state medical programs with regulatory oversight, patient-qualification requirements, and operational controls consistent with the rescheduling order. Adult-use-only licenses do not qualify. Operators with combined medical and adult-use licenses face eligibility questions that turn on how medical and adult-use activity are separated.

What happens if I didn’t apply within the 60-day window?

The 60-day window, which closed June 27, 2026, provided conditional operating authority while an application was pending. Operators who apply now can still register, but without that conditional authority, so federal authority is uncertain until DEA decides the application.

Does my state license automatically qualify me for federal registration?

No. State licensure is necessary but not sufficient. The federal application requires a public-interest analysis under 21 U.S.C. § 823, ownership and control disclosures, premises documentation, and a DEA determination that registration is consistent with the public interest. A state license is strong support for that determination; it does not replace the federal review.

Can I file a DEA registration application myself?

Yes; operators may file without counsel. Given the public-interest analysis, the documentation DEA expects, and the consequences of a deficient or denied application, it is worth deciding before filing whether to involve counsel. A denial can be harder to fix than a complete, well-supported first application.

Does the federal pathway cover adult-use operators?

Not under the current order. The § 1301.13(k) pathway is limited to qualifying state-medical activity. Kocot Law advises adult-use operators on their federal posture and on legislative and regulatory developments as they happen.

Have a federal cannabis question? The first 30 minutes are free.
Attorney advertising. This page is general information about federal cannabis law, not legal advice, and contacting the firm does not create an attorney-client relationship.
Scroll to Top